Update Feb 4, 03 #2
FDA announces the following:
FDA LAUNCHES INITIATIVE TO IMPROVE THE DEVELOPMENT AND AVAILABILITY OF
INNOVATIVE MEDICAL PRODUCTS
The Food and Drug Administration (FDA) today announced a broad initiative
to help make innovative medical technologies available sooner, and to reduce
the costs of developing safe and effective medical products while
maintaining FDA's traditional high standards of consumer protection. This is
an FDA-wide initiative, involving all four of FDA's medical product review
centers (drugs, biologics, devices, and veterinary medicine).
FDA intends to achieve this goal through new actions in three major
areas:
* Reducing the delays and avoidable product development costs by avoiding
multiple cycles of FDA review when possible, through early communication and
other steps to improve the quality of new product applications
* Improving the quality and efficiency of the review process, by adopting
a quality systems approach to medical product reviews
* Facilitating new product development, by providing clearer up-to-date
guidance for particular diseases and for emerging technologies
For more information on this initiative please visit the following:
Improving Innovation in Medical Technology: Beyond 2002
|
